Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05417217
Other study ID # f/2022/096
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 17, 2022
Est. completion date November 1, 2024

Study information

Verified date January 2024
Source Jessa Hospital
Contact Alaaddin Yilmaz, MD
Phone 011 33 71 04
Email alaaddin.yilmaz@jessazh.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to examine the influence of mechanical ventilation on the occurrence of myocardial ischemia in patients undergoing endo-CABG.


Description:

Coronary artery bypass grafting (CABG) surgery is one of the main treatment options for patients suffering from coronary artery disease, a condition characterized by a build-up of cholesterol in the coronary arteries of the heart that affects 126 million people worldwide each year. During this procedure, cardiopulmonary bypass (CPB) takes over the function of the heart and lungs. In recent years, there has been a huge focus on reducing surgical trauma in this procedure, leading to the emergence of minimally invasive cardiac surgery (MICS) such as endoscopic CABG (endo-CABG). In these techniques, peripheral CPB with femoral arterial cannulation is the most commonly used strategy. However, the use of retrograde arterial perfusion is not without risk. It can cause that the upper part of the body only receives deoxygenated blood. The effect on the heart is not yet fully known. The hypoxemia could cause myocardial ischemia and this could damage the heart muscle cells. It is reported in the literature that establishing adequate ventilation from the initiation of CPB to cardiac arrest can resolve this phenomenon. This approach was investigated in a recently performed double-blinded, randomized, controlled pilot study (n=10) of our research group. However, a larger randomized controlled trial was needed. Therefore, this research aims to investigate the effect of continued mechanical ventilation on the occurrence of myocardial ischemia in patients undergoing endo-CABG.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date November 1, 2024
Est. primary completion date September 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients older than 18 years old - Patients undergoing their first elective endo-CABG procedure using peripheral cannulation for CPB - Patients who are able to give their informed consent - Patients who speak Dutch or French Exclusion Criteria: - Patients participating in another clinical trial - Patients taking corticosteroids - Patients with an ejection fraction < 25% - Patients with lung diseases (chronic obstructive pulmonary disease (COPD), asthma) - Patients where groin cannulation is not possible

Study Design


Intervention

Procedure:
Discontinued ventilation
Ventilation is discontinued after going on CPB and lungs are exposed to atmospheric pressure
Continued ventilation
Ventilation is continued from going on CPB until clamping of the ascending aorta with tidal volume 3ml/kg ideal body weight, Fraction of inspired oxygen (FiO2) 50%, respiratory rate 5/min and Inspiratory:Expiratory (I/E) ratio 1/2.

Locations

Country Name City State
Belgium Jessa Hospital Hasselt

Sponsors (1)

Lead Sponsor Collaborator
Jessa Hospital

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary The influence of continued mechanical ventilation on the release of cardiac troponin T (cTn-T) Cardiac troponin T is represented in ng/L. If the value of cTn-T exceeds 14 ng/L, then cTn-T is able to detect myocardial ischemia at the predefined time points. Until 24 hours after clamping the aorta
Primary The influence of continued mechanical ventilation on the release of creatine kinase-myocardial band (CK-MB) Creatine kinase-myocardial (CK-MB) band is represented in µg/L. If the value of CK-MB exceeds 6.2 µg/L, then CK-MB is able to detect myocardial ischemia at the predefined time points. Until 24 hours after clamping the aorta
Primary The influence of continued mechanical ventilation on the release of heart-type fatty acid-binding protein (hFABP) Heart-type fatty acid-binding protein (hFABP) is represented in ng/L. If the value of hFABP exceeds 6 ng/L, then hFABP is able to detect myocardial ischemia at the predefined time points. Until 5 hours after clamping the aorta
Primary The influence of continued mechanical ventilation on lipid peroxidation Lipid peroxidation is measured using the malondialdehyde assay. Until unclamping the aorta (on average until 64 minutes after clamping the aorta)
Primary The influence of continued mechanical ventilation on the redox balance superoxide dismutase 1 and 2 (SOD1, SOD2), nuclear factor erythroid 2-related factor 2 (Nrf2), catalase (CAT), glutathione peroxidase (GPx), NADPH oxidase 2 and 4 (NOX2, NOX4), heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO-1)) will be studied to determine the redox balance. Until unclamping the aorta (on average until 64 minutes after clamping the aorta) ]
Primary The influence of continued mechanical ventilation on the partial pressure of oxygen (pO2) pO2 is represented in mmHg. If pO2 is lower than 60 mmHg, then hypoxemia is present. Until the end of surgery (on average until 203 minutes after the start of the surgery)
Primary The influence of continued mechanical ventilation on the partial pressure of carbon dioxide (pCO2) pCO2 is represented in mmHg. Until the end of surgery (on average until 203 minutes after the start of the surgery)
Primary The influence of continued mechanical ventilation on the pH The pH will measure the acidity. Until the end of surgery (on average until 203 minutes after the start of the surgery)
Primary The influence of continued mechanical ventilation on lactate Lactate is represented in mmol/L. Until the end of surgery (on average until 203 minutes after the start of the surgery)
Secondary The occurence of myocardial infarction This is based on the Fourth universal definition of myocardial infarction (2018). Until 30 days after surgery
Secondary The occurence of mortality All-cause mortality is evaluated. Until 30 days after surgery
Secondary The occurence of neurological complications Neurological complications include cerebrovascular accident (CVA), transient ischemic attack (TIA), delirium, epilepsy Until 30 days after surgery
Secondary The occurence of graft failure Graft failure describes total graft occlusion that prevents blood flow through the graft to the revascularized part of the heart. Until 30 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A